Cargando…

Single Stem Visceral Debranching for Complex Aortic Disease

OBJECTIVE: The treatment of complex aortic disease has been described with various retrograde visceral bypass techniques. An original technique with a single stem retrograde visceral graft (SSRVG) is presented. METHODS: This was a single centre retrospective study including 16 patients between 2015...

Descripción completa

Detalles Bibliográficos
Autores principales: Davaine, Jean-Michel, Jayet, Jérémie, Oiknine, Léa, Martin, Garance, Couture, Thibault, Verscheure, Dorian, Koskas, Fabien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920873/
https://www.ncbi.nlm.nih.gov/pubmed/35299720
http://dx.doi.org/10.1016/j.ejvsvf.2022.01.015
_version_ 1784669217979629568
author Davaine, Jean-Michel
Jayet, Jérémie
Oiknine, Léa
Martin, Garance
Couture, Thibault
Verscheure, Dorian
Koskas, Fabien
author_facet Davaine, Jean-Michel
Jayet, Jérémie
Oiknine, Léa
Martin, Garance
Couture, Thibault
Verscheure, Dorian
Koskas, Fabien
author_sort Davaine, Jean-Michel
collection PubMed
description OBJECTIVE: The treatment of complex aortic disease has been described with various retrograde visceral bypass techniques. An original technique with a single stem retrograde visceral graft (SSRVG) is presented. METHODS: This was a single centre retrospective study including 16 patients between 2015 and 2019. Patients were treated for aortic dissection (AD; type A and acute or chronic type B), thoraco-abdominal aortic aneurysms (TAAAs), and visceral occlusive disease. Surgery consisted of visceral vessel debranching from the native infrarenal aorta or from an aortic graft. In the case of AD, surgical fenestration was performed. Additional thoracic endovascular aneurysm repair (TEVAR) completed the treatment when indicated, during the same procedure or later. Patient outcomes and reconstruction patency were studied. RESULTS: The mean patient age was 64 years (median 68 ± 12.6). Ten (62%) patients were treated for AD, three (19%) for TAAA, and three (19%) for occlusive disease. Sixty-nine target vessels were debranched with this SSRVG technique. Aortic surgical fenestration was performed in eight cases and TEVAR in four. During their hospital stay, three (19%) TAAA patients died, seven cases of renal insufficiency (44%), four cases of pneumonia (25%), and three colonic ischaemia cases (19%) were noted. After a mean follow up of 21 months, no other deaths occurred. All vessels (except two inferior mesenteric arteries) were patent and no endoleak was noted. CONCLUSION: The SSRVG technique can be offered in various complex aortic diseases. The use of a single graft is feasible and reduces the volume of multiple branch assembly in the retroperitoneal space. The observed patency rate is high.
format Online
Article
Text
id pubmed-8920873
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89208732022-03-16 Single Stem Visceral Debranching for Complex Aortic Disease Davaine, Jean-Michel Jayet, Jérémie Oiknine, Léa Martin, Garance Couture, Thibault Verscheure, Dorian Koskas, Fabien EJVES Vasc Forum Original Research OBJECTIVE: The treatment of complex aortic disease has been described with various retrograde visceral bypass techniques. An original technique with a single stem retrograde visceral graft (SSRVG) is presented. METHODS: This was a single centre retrospective study including 16 patients between 2015 and 2019. Patients were treated for aortic dissection (AD; type A and acute or chronic type B), thoraco-abdominal aortic aneurysms (TAAAs), and visceral occlusive disease. Surgery consisted of visceral vessel debranching from the native infrarenal aorta or from an aortic graft. In the case of AD, surgical fenestration was performed. Additional thoracic endovascular aneurysm repair (TEVAR) completed the treatment when indicated, during the same procedure or later. Patient outcomes and reconstruction patency were studied. RESULTS: The mean patient age was 64 years (median 68 ± 12.6). Ten (62%) patients were treated for AD, three (19%) for TAAA, and three (19%) for occlusive disease. Sixty-nine target vessels were debranched with this SSRVG technique. Aortic surgical fenestration was performed in eight cases and TEVAR in four. During their hospital stay, three (19%) TAAA patients died, seven cases of renal insufficiency (44%), four cases of pneumonia (25%), and three colonic ischaemia cases (19%) were noted. After a mean follow up of 21 months, no other deaths occurred. All vessels (except two inferior mesenteric arteries) were patent and no endoleak was noted. CONCLUSION: The SSRVG technique can be offered in various complex aortic diseases. The use of a single graft is feasible and reduces the volume of multiple branch assembly in the retroperitoneal space. The observed patency rate is high. Elsevier 2022-02-04 /pmc/articles/PMC8920873/ /pubmed/35299720 http://dx.doi.org/10.1016/j.ejvsvf.2022.01.015 Text en © 2022 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Davaine, Jean-Michel
Jayet, Jérémie
Oiknine, Léa
Martin, Garance
Couture, Thibault
Verscheure, Dorian
Koskas, Fabien
Single Stem Visceral Debranching for Complex Aortic Disease
title Single Stem Visceral Debranching for Complex Aortic Disease
title_full Single Stem Visceral Debranching for Complex Aortic Disease
title_fullStr Single Stem Visceral Debranching for Complex Aortic Disease
title_full_unstemmed Single Stem Visceral Debranching for Complex Aortic Disease
title_short Single Stem Visceral Debranching for Complex Aortic Disease
title_sort single stem visceral debranching for complex aortic disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920873/
https://www.ncbi.nlm.nih.gov/pubmed/35299720
http://dx.doi.org/10.1016/j.ejvsvf.2022.01.015
work_keys_str_mv AT davainejeanmichel singlestemvisceraldebranchingforcomplexaorticdisease
AT jayetjeremie singlestemvisceraldebranchingforcomplexaorticdisease
AT oikninelea singlestemvisceraldebranchingforcomplexaorticdisease
AT martingarance singlestemvisceraldebranchingforcomplexaorticdisease
AT couturethibault singlestemvisceraldebranchingforcomplexaorticdisease
AT verscheuredorian singlestemvisceraldebranchingforcomplexaorticdisease
AT koskasfabien singlestemvisceraldebranchingforcomplexaorticdisease